Our Inspiration
- Living With Rare Diseases
- Real Stories
  - NF1
  - aHUS
  - gMG
  - HPP
  - LAL-D
  - NMOSD
  - PNH
- Support Services
Albie, one of our guiding stars

When Albie was born, his mom, Charlotte, said that he was “absolutely fine. Everything was fine for about two weeks.”
Our Medicines
- Conditions We Treat
  - aHUS
  - gMG
  - HPP
  - LAL-D
  - NF1 PN
  - NMOSD
  - PNH
- Medicines
Our medicines help people like Donnan

As a father of two young children, Donnan recalls being afraid of what the future would hold prior to his diagnosis.
Our Research
We innovate for Ruthie

Married with a newborn son, Ruthie was scared to learn that PNH was a life-threatening illness that at the time had no approved treatment.
Our Commitment
We give back for families like Evie's

At only three months old, Evie's parents were told that her case was severe and that there were no approved or effective treatment options.
Our Company
Liz is our inspiration

Although physical challenges required Liz, her husband, and their children to adjust their lives in many ways, she doesn't let her disease hold her back.
Your Career
- Career Opportunities
  - Join Our Team
- Working Here
  - Benefits
  - Culture
Make a difference for families like Tristan's

Tristan's parents experienced a whirlwind of emotions and fear after learning their 5-year-old son had such a rare and serious disease.

LEADERSHIP

Gianluca Pirozzi

SVP, Head of Development, Regulatory and Safety

Gianluca Pirozzi is Senior Vice President, Head of Development and Safety of Alexion, AstraZeneca Rare Disease.

Connect

About Gianluca

Gianluca joined Alexion in October 2019 and currently leads the company’s integrated Development, Regulatory and Safety organization. Previously, he served in various roles at Sanofi Genzyme, including Head of Development for Rare Diseases and Gene Therapy. He has served on the Board of Directors of Imbria Pharmaceuticals for two years, and is currently Board Member of Timber Pharmaceuticals, as well as scientific advisor for the Smith-Magenis Syndrome Research Foundation.

Gianluca holds an MD degree from University Campus Bio-Medico and a PhD in Immunology from Sapienza University, both in Rome, Italy, and completed a Post Doctoral Research Fellowship in Immunology at the Pasteur Institute in Paris, France.

Evie, diagnosed with HPP at 2 weeks old, riding a toy car

Her story gives other parents with special needs kids hope that they can be okay, and things can be good.”

LINDSEY, EVIE’S MOM LIVING WITH HPP

HEAR HER STORY

Gianluca Pirozzi

SVP, Head of Development, Regulatory and Safety

About Gianluca

You are now leaving www.alexion.com, a website provided by Alexion Pharmaceuticals, Inc. This link will take you to a different site to which this Privacy Policy does not apply.

You are now leaving the alexion.com UK webpage for the global alexion.com website. The content on the global site is intended for a U.S. audience only